Drug Type Chemical drugs |
Synonyms- |
Target |
Action antagonists |
Mechanism KIF20A antagonists(kinesin family member 20A antagonists) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhaseDiscontinuedPreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Solid tumor | Preclinical | France | 01 Feb 2022 |